“…Transplant complications arise as a result of the conditioning regimen, the new donor-derived immune system, sequelae from prolonged immunosuppressant treatments that prevent acute and chronic graft-versus-host disease and side effects from supportive medications (Arnaout et al, 2014; Bevans et al, 2014; Mitchell et al, 2010; Pidala, Anasetti, & Jim, 2009; Tichelli, Rovo, & Socie, 2012). In addition to these biological effects, unpleasant symptoms, functional impairment, and psychosocial distress (for example fear of recurrence) can have a deleterious impact on several patient-centered outcomes, including health-related quality of life (HRQL) (Bevans et al, 2014; Gifford, Sim, Horne, & Ma, 2014; Kenzik, Huang, Rizzo, Shenkman, & Wingard, 2014; Mitchell et al, 2010; Mohty & Mohty, 2011; Norkin, Hsu, & Wingard, 2012; Pidala et al, 2009; Sarkar et al, 2014; Syrjala et al, 2012; Tichelli et al, 2012). …”